Correlation Between Orchestra BioMed and Innate Pharma
Can any of the company-specific risk be diversified away by investing in both Orchestra BioMed and Innate Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Orchestra BioMed and Innate Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Orchestra BioMed Holdings and Innate Pharma, you can compare the effects of market volatilities on Orchestra BioMed and Innate Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Orchestra BioMed with a short position of Innate Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Orchestra BioMed and Innate Pharma.
Diversification Opportunities for Orchestra BioMed and Innate Pharma
0.55 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Orchestra and Innate is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Orchestra BioMed Holdings and Innate Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innate Pharma and Orchestra BioMed is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Orchestra BioMed Holdings are associated (or correlated) with Innate Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innate Pharma has no effect on the direction of Orchestra BioMed i.e., Orchestra BioMed and Innate Pharma go up and down completely randomly.
Pair Corralation between Orchestra BioMed and Innate Pharma
Given the investment horizon of 90 days Orchestra BioMed is expected to generate 1.01 times less return on investment than Innate Pharma. In addition to that, Orchestra BioMed is 1.37 times more volatile than Innate Pharma. It trades about 0.01 of its total potential returns per unit of risk. Innate Pharma is currently generating about 0.02 per unit of volatility. If you would invest 300.00 in Innate Pharma on February 4, 2024 and sell it today you would lose (45.00) from holding Innate Pharma or give up 15.0% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Orchestra BioMed Holdings vs. Innate Pharma
Performance |
Timeline |
Orchestra BioMed Holdings |
Innate Pharma |
Orchestra BioMed and Innate Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Orchestra BioMed and Innate Pharma
The main advantage of trading using opposite Orchestra BioMed and Innate Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Orchestra BioMed position performs unexpectedly, Innate Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innate Pharma will offset losses from the drop in Innate Pharma's long position.Orchestra BioMed vs. PaxMedica Common Stock | Orchestra BioMed vs. Revelation Biosciences | Orchestra BioMed vs. Virax Biolabs Group | Orchestra BioMed vs. Neurobo Pharmaceuticals |
Innate Pharma vs. Eliem Therapeutics | Innate Pharma vs. HCW Biologics | Innate Pharma vs. InhibrxInc | Innate Pharma vs. Anebulo Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
CEOs Directory Screen CEOs from public companies around the world | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |